Genome Editing for the Treatment of Neurofibromatosis Type I

syn33820507

Created By Madeleine Sitton msitton

dataType: AlignedReads image
studyName: Genome Editing for the Treatment of Neurofibromatosis Type I
dataStatus: Under Embargo
initiative: Gene Therapy Initiative
studyLeads: Charles Gersbach
studyStatus: Active
diseaseFocus: Neurofibromatosis type 1
grantEndDate: 1735603200000
institutions: Duke University
fundingAgency: GFF
embargoEndDate: 1767139200000
grantStartDate: 1640995200000
relatedStudies: syn37872335 syn21641872 syn36530086 syn21641931
studyFileviewId: syn37237915
syn37239876
syn33820515
syn53335423
syn37240250
syn53604816
syn37237915
syn64495154
syn63687666

Your web browser must have JavaScript enabled in order for this application to display correctly.
If you are an automated web crawler from a search engine, follow this AJAX application crawl link

Genome Editing for the Treatment of Neurofibromatosis Type I

syn33820507

Drop files to upload

Genome Editing for the Treatment of Neurofibromatosis Type I page is loading…